Healios K.K.
HLOSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $128 | $22,000 | $38,000 | $18,000 |
| % Growth | -99.4% | -42.1% | 111.1% | – |
| Cost of Goods Sold | $764 | $68,000 | $29,000 | $30,000 |
| Gross Profit | -$635 | -$46,000 | $9,000 | -$12,000 |
| % Margin | -494.7% | -209.1% | 23.7% | -66.7% |
| R&D Expenses | $3,157 | $584,000 | $482,000 | $486,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,372 | $235,000 | $290,000 | $363,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $9,000 |
| Operating Expenses | $4,529 | $819,000 | $772,000 | $858,000 |
| Operating Income | -$5,165 | -$865,000 | -$763,000 | -$870,000 |
| % Margin | -4,021.1% | -3,931.8% | -2,007.9% | -4,833.3% |
| Other Income/Exp. Net | $9,011 | -$1,260,000 | -$1,816,000 | $1,312,000 |
| Pre-Tax Income | $3,846 | -$2,125,000 | -$2,579,000 | $442,000 |
| Tax Expense | $41 | $21,000 | $16,000 | $194,000 |
| Net Income | $3,806 | -$2,148,000 | -$2,562,000 | $256,000 |
| % Margin | 2,963.2% | -9,763.6% | -6,742.1% | 1,422.2% |
| EPS | 0.033 | -20.57 | -26.72 | 2.84 |
| % Growth | 100.2% | 23% | -1,040.8% | – |
| EPS Diluted | 0.033 | -20.57 | -26.72 | 2.84 |
| Weighted Avg Shares Out | 115,453 | 104,407 | 95,877 | 90,156 |
| Weighted Avg Shares Out Dil | 115,453 | 104,407 | 95,877 | 90,156 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,805 | $0 | $0 | $2,488,000 |
| Interest Expense | $0 | $1,294,000 | $1,835,000 | $0 |
| Depreciation & Amortization | $460 | $67,000 | $68,000 | $80,000 |
| EBITDA | $4,306 | -$763,000 | -$676,000 | -$792,000 |
| % Margin | 3,352.6% | -3,468.2% | -1,778.9% | -4,400% |